← FDA Drug Approvals (Drugs@FDA)
BESREMI
BLA · Biologics License Application · Sponsor: PHARMAESSENTIA CORP · Approved 2021-11-12
Drug application
- FDA Application #
BLA761166- Application type
- Biologics License Application
- Brand name
- BESREMI
- Generic name
- ROPEGINTERFERON ALFA-2B
- Active ingredients
- ROPEGINTERFERON ALFA-2B-NJFT
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- PHARMAESSENTIA CORP
- Manufacturer
- PharmaEssentia USA
- First approval
- 2021-11-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown